Rainbow Childrens Medicare Q1 Results: Net Profit Rises to ₹606M, Revenue Up 33% YoY

2 min read     Updated on 30 Jul 2026, 06:08 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Rainbow Children's Medicare posted Q1 consolidated net profit of ₹606 million, up from ₹534 million year-on-year, as revenue climbed to ₹4.7 billion from ₹3.53 billion. EBITDA rose to ₹1.35 billion from ₹1 billion, though EBITDA margin dipped to 28.66% from 29.38%. The company also announced two hospital acquisitions and a senior management appointment during the period.

powered bylight_fuzz_icon
46959878

*this image is generated using AI for illustrative purposes only.

Rainbow Children's Medicare Limited reported a consolidated net profit of ₹606 million for Q1, up from ₹534 million in the year-ago period. Consolidated revenue from operations rose to ₹4.7 billion from ₹3.53 billion year-on-year, reflecting strong demand across its healthcare network. The company also posted a standalone net profit of ₹527.06 million, compared to ₹517.20 million in the prior year period.

The results were reviewed by statutory auditors S.R. Batliboi & Associates LLP and approved by the Board of Directors on July 30, 2026, pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board also approved the elevation of Mr. Anshuman Jaiswal from Group Head – Legal to Chief Legal Officer, designating him as Senior Management Personnel with immediate effect.

Financial Performance

Consolidated EBITDA came in at ₹1.35 billion, compared to ₹1 billion in the year-ago period, while EBITDA margin stood at 28.66% versus 29.38% year-on-year, indicating modest margin compression despite strong top-line growth. Consolidated total income reached ₹4,826.95 million, supported by other income of ₹127.10 million. Total expenses stood at ₹3,987.42 million, with professional fees to doctors rising to ₹1,238.19 million from ₹917.58 million in the prior year period. Profit before tax was ₹839.53 million, against ₹713.74 million in the corresponding quarter of the previous year.

The following table summarises key consolidated financial metrics for the quarter:

Metric: Q1FY26 Q1FY25 Change (YoY)
Revenue from Operations: ₹4.7 billion ₹3.53 billion Higher
Net Profit After Tax: ₹606 million ₹534 million Higher
EBITDA: ₹1.35 billion ₹1 billion Higher
EBITDA Margin: 28.66% 29.38% Lower

Standalone revenue from operations increased 22.6% to ₹4,105.47 million. Standalone profit before tax was ₹705.41 million, compared to ₹688.20 million in the prior year period. Basic earnings per share on a standalone basis rose to ₹5.20 from ₹5.09 in the prior year period.

Strategic Developments

Subsequent to the quarter end, the company executed definitive transaction documents for a new children and women's hospital at Malad, Mumbai, through its wholly owned subsidiary Rainbow Women & Children's Hospital Private Limited. The transaction is expected to complete in the quarter ended September 30, 2026.

Additionally, Rainbow Children's Medicare Limited signed a Partnership Interest and Contribution Transfer Agreement to acquire a 64% stake in Super Prime Medical Care LLP for an aggregate consideration of ₹198 million. This acquisition targets a running children's hospital in Nellore, Andhra Pradesh, with completion also expected in the quarter ended September 30, 2026.

Key Takeaways

The slight contraction in EBITDA margin — from 29.38% to 28.66% — alongside robust revenue growth underscores margin pressure from higher professional fees to doctors, which grew significantly year-on-year. While patient volumes are expanding rapidly, the cost structure is scaling proportionally, requiring careful management of doctor compensation relative to service pricing to sustain profitability gains.

Historical Stock Returns for Rainbow Childrens Medicare

1 Day5 Days1 Month6 Months1 Year5 Years
+1.60%+2.06%+8.19%+28.36%-0.30%+237.76%

How will the integration of the new Malad hospital and the Nellore acquisition impact Rainbow Children's Medicare's EBITDA margins in the short term, given the current pressure from rising doctor fees?

What specific strategies is management implementing to control the year-on-year surge in professional fees to doctors without compromising patient volume growth?

Will the capital expenditure required for the Malad and Nellore expansions necessitate external financing, and how might this affect the company's debt-to-equity ratio?

Rainbow Childrens Medicare
View Company Insights
View All News
like15
dislike

Rainbow Childrens Medicare sets up Guntur hospital with ₹15 crore investment

2 min read     Updated on 30 Jul 2026, 01:43 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Rainbow Childrens Medicare Limited is investing ₹15 crore from internal accruals to open a 50-bed women's and children's hospital in Guntur, Andhra Pradesh. The facility, housed in an existing building to reduce capex and timeline, aims to boost the company's presence in the region. Operations are slated to begin by September 2026, adding to the current 2,435-bed network which operates at 46.3% utilization.

powered bylight_fuzz_icon
46901583

*this image is generated using AI for illustrative purposes only.

Rainbow Childrens Medicare has announced a strategic expansion into Guntur, Andhra Pradesh, through the establishment of a new women's and children's hospital. The company disclosed on July 29, 2026, that it has executed a long-term lease for the premises, marking a move to strengthen its healthcare delivery network in the state. This initiative is designed to enhance access to specialized care while leveraging an existing infrastructure to accelerate operational timelines.

The disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the SEBI Master Circular dated January 30, 2026. The company stated that the leased premises comprise a newly built hospital building with requisite healthcare infrastructure. This approach allows for a faster operational ramp-up with relatively lower execution timelines and capital expenditure compared to a greenfield development. The information was submitted to the National Stock Exchange of India Limited and BSE Limited.

Project Financials and Capacity

The proposed capacity addition represents a targeted growth in the company's bed count. As of the date of disclosure, Rainbow Childrens Medicare Limited operates an existing capacity of 2,435 beds with a utilization rate of 46.3%. The new facility in Guntur will add an incremental capacity of 50 beds. The total investment required for this project is approximately ₹15 crore, which will be financed entirely through internal accruals.

Metric Details
Existing Capacity 2,435 beds
Existing Utilization 46.3%
Proposed Addition 50 beds
Investment Required ₹15 crore
Financing Mode Internal Accruals
Expected Commissioning September 2026

Strategic Rationale

Management indicated that the Guntur facility is expected to support the company's long-term growth strategy by expanding its presence in Andhra Pradesh. The hospital will focus on specialized women's and children's healthcare services, aligning with the company's core brand identity. The utilization of an existing building rather than constructing a new one is cited as a key factor in reducing capital intensity and shortening the time to market.

What the Numbers Show

The decision to finance the ₹15 crore expansion through internal accruals suggests confidence in the company's cash flow generation capabilities without resorting to external debt or equity dilution. With existing capacity utilization standing at 46.3%, there is significant room for organic growth within the current network before the new beds come online. The addition of 50 beds represents a modest 2.05% increase in total capacity, indicating a measured, low-risk approach to geographic expansion. The focus on a specialized segment (women and children) in a tier-2 city like Guntur may offer higher margin potential compared to general hospitals, assuming demand matches supply.

The proposed capacity is expected to be commissioned by September 2026, subject to the receipt of necessary approvals and completion of construction or development activities. Shreya Mitra, Company Secretary and Compliance Officer, signed the intimation letter.

Historical Stock Returns for Rainbow Childrens Medicare

1 Day5 Days1 Month6 Months1 Year5 Years
+1.60%+2.06%+8.19%+28.36%-0.30%+237.76%

How might the low existing utilization rate of 46.3% impact the return on investment for the new Guntur facility compared to expanding in higher-demand metropolitan areas?

What specific regulatory approvals or local infrastructure challenges could delay the September 2026 commissioning timeline for the leased premises?

Will Rainbow Childrens Medicare pursue similar lease-based expansions in other tier-2 cities in Andhra Pradesh to replicate this low-capital-intensity growth model?

Rainbow Childrens Medicare
View Company Insights
View All News
like17
dislike

More News on Rainbow Childrens Medicare

1 Year Returns:-0.30%